Yunnan Baiyao "Leaked Secret Door" Exposed "Compound Chinese Medicine" Internationalized Injury

Business Club December 27th Insiders believe that Yunnan Baiyao and other traditional Chinese medicines can only enter the United States and other overseas markets in the form of dietary supplements and food, and cannot enter the mainstream pharmaceutical market abroad as pharmaceuticals.

Leaked or involved double standards challenged

As to whether the Yunnan Baiyao confidential formula was leaked in the United States, a reporter from the China Economic Times on the 24th called Wei Bo, the general manager of Yunnan Baiyao Group Co., Ltd.’s Overseas Business Department, to be informed that “Yunnan Baiyao did not violate the confidentiality principle.”

Prior to this, the "Mdoctor" published by the user, "Yunnan Baiyao, who is confidential? The post stated that a document on the US Food and Drug Administration (FDA) website listed the composition and content of “Yunnan Baiyao”, which clearly indicated the use of Chinese herbal medicines such as schisandra, biloba and other herbs. Ingredient and content. However, the specific ingredients of Yunnan Baiyao are not listed in the domestic sales brochure of Yunnan Baiyao.

As to whether Yunnan Baiyao was leaked in the United States, Wei Bo did not answer it directly, but Wei Bo told this reporter that “the senior management of the Yunnan Baiyao Group had responded to an interview with the Xinhua News Agency reporters a few days ago. The double standard for foreigners’ privacy is nonexistent."

Some experts pointed out that "prescription" and "ingredients" are not the same, and the Ministry of Health requires that confidentiality refer to "prescription" and not "components." In other words, even if you know the ingredients of drugs, you do not know the drugs because Dosage, craftsmanship, and other information, can not make the real drugs.

However, the China Economic Times reporter logged in to Chinese Natural Herbs. Com and other sites, enter the keyword "baiyao", can find specific ingredients on Yunnanbaiyao, and can easily see the specific dose of ingredients.

Chinese medicines often enter the country as health products

In August 1984, the State Administration of Medicine (predecessor of the State Food and Drug Administration) listed the formula and technology of Yunnan Baiyao as top secret in the country.

According to Yunnan Baiyao Group website, Yunnan Baiyao products mainly consist of Yunnan Baiyao series and natural medicine series, with 19 formulations and more than 300 varieties. According to the website of the State Food and Drug Administration, "Yunnan Baiyao" and "Yunnan Baiyao Capsule" are currently "Class 1 Protected Species."

According to Article 13 of the “Regulations on the Protection of Chinese Medicinal Plant Varieties”, “the prescription composition and process method for the first class protection of Chinese medicine, the production enterprise and the related pharmaceutical production and operation manager shall obtain the “Certificate for the Protection of Chinese Medicinal Products” within the term of protection. Departments, health administrative departments and related units and individuals are responsible for confidentiality and shall not be open to the public."

The industry experts interviewed by this reporter generally believe that in addition to these two types of “first-class protection varieties,” Yunnan Baiyao series of medicines such as Yunnan Baiyao Band-Aid, Yunnan Baiyao Toothpaste and other ingredients are also known as “national secret formulas”. Suspected of hitchhiking.

People who do not wish to be named pointed out that in order to comply with the FDA regulations or to meet the special needs of specific foreign consumers, some domestic pharmaceutical companies may modify the formula of their products to allow them to enter the United States as Health Care products. Other overseas markets. Entering as a drug requires a phase III clinical trial to be approved for listing.

"Compound" ingredient or blocking the internationalization of Chinese medicine

Zhang Fabao, chairman and president of Bio Valley Group, pointed out in an interview with a reporter from the China Economic Times that people outside the ring saw the appearance of leaks and other appearance problems, while professionals saw those that reflected the universal presence in the internationalization of Chinese medicine. The key issue.

The industry experts interviewed by this reporter have pointed out that Yunnan Baiyao must enter the mainstream pharmaceutical market abroad as a medicine. Traditional Chinese medicines generally enter the United States and other overseas markets in the form of dietary supplements and food, but the market is narrow.

According to our reporter, it is difficult for Yunnan Baiyao to enter the mainstream market for Western medicine. “It is almost impossible to amend foreign laws and regulations, and compound ingredients are inherent characteristics of Chinese medicine. In this sense, the road to internationalization of Yunnanbaiyao has entered a dilemma.” Zhang Fabao pointed out.

According to industry sources, Yunnan Baiyao is currently entering the drug and makeup market. Due to the “Leakage Gate” incident, this pace may be delayed and the price adjustment measures for Yunnan Baiyao-related products may also be postponed.